Ms. Laurie S. Evans, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7425 Wrigley Dr., Ste 204, Pasco, WA 99301 Phone: 509-547-0027 Fax: 509-546-8386 |
Mr. Richard W Shallman, MD Surgery Medicare: Medicare Enrolled Practice Location: 7425 Wrigley Dr Ste 204, Pasco, WA 99301 Phone: 509-547-0027 Fax: 509-547-6946 |
Dr. Ashlea Kirstin Mcmanus, MD Surgery Medicare: Medicare Enrolled Practice Location: 520 N 4th Ave, Pasco, WA 99301 Phone: 509-547-7704 |
William K Trzcinski, MD Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 N 14th Ave, #240, Pasco, WA 99301 Phone: 509-547-0675 Fax: 509-547-0584 |
Alfred Monteilh Jr., MD Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 N 14th Ave, #240, Pasco, WA 99301 Phone: 509-547-0675 Fax: 509-547-0584 |
Dr. Jason David Wright, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 5908 Bedford St Ste C, Pasco, WA 99301 Phone: 509-792-1404 Fax: 509-792-1404 |
News Archive
The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
A vaginal microbicide that incorporates an antiretroviral (ARV) drug normally used to treat people with HIV is safe for sexually active HIV-negative women to use every day over an extended period, suggest results of a clinical trial of tenofovir topical gel.
WLBT: "The White House Office of National AIDS Policy chose Jackson [Mississipppi] to host an HIV/AIDS town hall meeting Monday night. The community discussion allowed Mississippians to give feedback that will be included in a national strategy to end the HIV/AIDS epidemic. ... Many asked for sex and STD education in the schools, more doctors and transportation funding in rural areas and health insurance" (Anderson, 11/17).
Called the "Little Women," six women who have spent the past three years listening, documenting and researching parental concerns about Gardasil have been invited to formally present their information to the FDA on March 12. FDA participants include the Office of Communication, Outreach and Development/Center of Biologics (CBER), Office of Biostatistics and Epidemiology, and Office of Vaccines Research and Review.
An international research team led by the University of Bonn (Germany) has identified and further developed novel antibody fragments against the SARS coronavirus-2. These "nanobodies" are much smaller than the classic antibodies used to treat US President Donald Trump, for example.
› Verified 2 days ago